Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 5
Submit an article Journal homepage
921
Views
1
CrossRef citations to date
0
Altmetric
Coronavirus – Commentary

Using a “systems therapeutic for physiological renormalization” approach to vaccine development. Covid-19 as an example

Greg MaguireLaboratories, The California Physiological Society2425 Channing Way, Berkeley, CA 94704 2425 Channing Way, Berkeley, CA 94704 Berkeley, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-5484-6157
ORCID Icon
Article: 2043105 | Received 24 Jan 2022, Accepted 12 Feb 2022, Published online: 03 Mar 2022

References

  • Joyce MG, King HA, Elakhal-Naouar I, Ahmed A, Peachman KK, Macedo Cincotta C, Subra C, Chen RE, Thomas PV, Chen WH, et al. A SARS-CoV-2 ferritin nanoparticle vaccine elicits protective immune responses in nonhuman primates. Sci Transl Med. 2021. doi:10.1126/scitranslmed.abi5735.
  • Kundu R, Narean JS, Wang L, Fenn J, Pillay T, Fernandez ND, Conibear E, Koycheva A, Davies M, Tolosa-Wright M, et al. Cross-Reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat Commun. 2022;13(1):80. doi:10.1038/s41467-021-27674-x.
  • Bates TA, McBride SK, Winders B, Schoen D, Trautmann L, Curlin ME, Tafesse FG. Antibody response and variant cross-neutralization after SARS-CoV-2 breakthrough infection. JAMA. doi:10.1001/jama.2021.22898.
  • Russell MW, Moldoveanu Z, Ogra PL, Mestecky J. Mucosal immunity in COVID-19: a neglected but critical aspect of SARS-CoV-2 infection. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.611337.
  • Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, Jehn M, Pogreba-Brown K. Post-Acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS ONE. 2021;16(8):e0254347. doi:10.1371/journal.pone.0254347.
  • Liu S, Hossinger A, Heumüller SE, Hornberger A, Buravlova O, Konstantoulea K, Müller SA, Paulsen L, Rousseau F, Schymkowitz J, et al. Highly efficient intercellular spreading of protein misfolding mediated by viral ligand-receptor interactions. Nat Commun. 2021;12(1):5739. doi:10.1038/s41467-021-25855-2.
  • Maguire G. Systems biology approach to developing “systems therapeutics”. ACS Med Chem Lett. 2014;5(5):453–2. doi:10.1021/ml5000614. PMID: 24900858; PMCID: PMC4027758.
  • Maguire G. Physiological renormalization using systems therapeutics. Future Sci OA. 2019 ;6(1):FSO428. doi:10.2144/fsoa-2019-0106. PMID: 31915529; PMCID: PMC6920733.
  • Maguire G. Stem cells part of the innate and adaptive immune systems as a therapeutic for Covid-19. Commun Integr Biol. 2021;14(1):186–98. doi:10.1080/19420889.2021.1965356.
  • Chang SE, Feng A, Meng W, Apostolidis SA, Mack E, Artandi M, Barman L, Bennett K, Chakraborty S, Chang I, et al. New-Onset IgG autoantibodies in hospitalized patients with COVID-19. Nat Commun. 2021;12(1):5417. doi:10.1038/s41467-021-25509-3.
  • de Bruijn S, Maes M-B, De Waele L, Vanhoorelbeke K, Gadisseur A. First report of a de novo iTTP episode associated with an mRNA-based anti-COVID-19 vaccination. J Thromb Haemost. 2021 ;19(8):2014–18. doi:10.1111/jth.15418. Epub 2021 Jul 5. PMID: 34105244; PMCID: PMC8236927.
  • Mallapaty S. Chinaʻs COVID vaccines have been crucial — now immunity is waning. Nature. 2021;598(7881):398–99. doi:10.1038/d41586-021-02796-w.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.